Cargando…

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape

Background: Dyslipidemia is an important comorbid factor of type 2 diabetes mellitus (T2DM) that increases the risk of cardiovascular diseases. This study aimed to assess the pattern of dyslipidemia and atherogenic indices and determine its relation with glycemic control. Methods:A cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bage, Isaac J, Kamalanathan, Sadishkumar, Selvarajan, Sandhiya, Sahoo, Jayaprakash, Jayanthi, Mathaiyan, Naik, Dukhabandhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601505/ https://www.ncbi.nlm.nih.gov/pubmed/37900537 http://dx.doi.org/10.7759/cureus.45985

Ejemplares similares

Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia
por: Bage, Isaac J., et al.
Publicado: (2023)

ODP166 Autoantibody Positivity and Random C-peptide Profile in Young Ethnic South Indian Population with Diabetes Mellitus
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
por: Narayanan, Niya, et al.
Publicado: (2022)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

The Risk of Fractures in Primary Hyperparathyroidism: A Meta‐Analysis
por: Narayanan, Niya, et al.
Publicado: (2021)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
por: Makhoul, Elias, et al.
Publicado: (2022)

Level of Control of Dyslipidemia Among Patients Followed in Family Medicine Clinics in Riyadh, Saudi Arabia
por: Hadi, Amal, et al.
Publicado: (2021)

Prevalence of Dyslipidemia in Ischemic Stroke Patients: A Single-Center Prospective Study From Pakistan
por: Khan, Raja Sheraz Ullah, et al.
Publicado: (2022)

G1359A Polymorphism of the Cannabinoid Receptor 1 Is Not Associated with Overweight and Dyslipidemia in Young Northeastern Mexicans
por: Rodríguez-Rodríguez, Ismael, et al.
Publicado: (2019)

THU416 Trabecular Bone Score, Bone Mineral Density, And Fractures In Patients Of Chronic Kidney Disease With And Without Diabetes Mellitus
por: Suryadevara, Varun, et al.
Publicado: (2023)

The Association Between Anti-Thyroid Peroxidase Antibody and Dyslipidemia in Subclinical Hypothyroidism Among the Rural Population of Central India
por: Kumar, Manoj, et al.
Publicado: (2022)

Timing of osteoporosis therapies following fracture: the current status
por: Palui, Rajan, et al.
Publicado: (2022)

Growth hormone and gastrointestinal malignancy: An intriguing link
por: Palui, Rajan, et al.
Publicado: (2023)

Treatment on Nature’s lap: Use of herbal products in the management of hyperglycemia
por: Giri, Somdatta, et al.
Publicado: (2023)

A Descriptive Study of Atherogenic Indices in Patients Admitted to a Tertiary Care Hospital
por: Dharmaraj, Saranya, et al.
Publicado: (2022)

Prevalence and Regulation of Dyslipidemia Among Adults With Type 2 Diabetes From Three Primary Health Care Centers in Riyadh
por: Bin Saleh, Fatemah S, et al.
Publicado: (2022)

Spectrum of Dyslipidemias in Treatment-Naïve Human Immunodeficiency Virus-Infected Patients Presenting to an HIV Clinic of a Tertiary Care Hospital
por: Iqbal, Sadaf, et al.
Publicado: (2022)

Dyslipidemia Among Diabetes Mellitus Patients: A Case-Control Study From a Tertiary Care Hospital in South India
por: Latha, VL Asha, et al.
Publicado: (2023)

Islet cell dysfunction in patients with chronic pancreatitis
por: Roy, Ayan, et al.
Publicado: (2020)

Diabetes and pancreatic cancer: Exploring the two-way traffic
por: Roy, Ayan, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence
por: Roy, Ayan, et al.
Publicado: (2021)

Utilization of Hypolipidemic Drugs, Patterns, and Factors Affecting Dyslipidemia Among Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital in South India
por: Khot, Sandeep, et al.
Publicado: (2023)

SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
por: Raj, Henith, et al.
Publicado: (2019)

Pediatric Adrenocortical Oncocytoma presenting as Cushing’s Syndrome and Peripheral Precocious Puberty: A Case Report and Review of Literature*
por: Narayanan, Niya, et al.
Publicado: (2021)

Abstract 145: Etiological profile of precocious puberty: A JIPMER experience
por: Suryadevara, Varun, et al.
Publicado: (2022)

Adrenal crisis in a patient with APS2 due to COVID-19: A case report
por: Suryadevara, Varun, et al.
Publicado: (2022)

Abstract 128: Thyroid function abnormalities in hospitalized patients with COVID-19 infection – A cross-sectional study
por: Rashmi, K G, et al.
Publicado: (2022)

Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis
por: Palui, Rajan, et al.
Publicado: (2020)

Clinical Features of Unrecognized Congenital Adrenal Hyperplasia Due to 17α-hydroxylase Deficiency Since Adolescence: A Case Report
por: Rashmi, KG, et al.
Publicado: (2023)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Role of the Gut in Diabetic Dyslipidemia
por: Stahel, Priska, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qbvcfpbdle8qg0a4ivk2cpsge5